Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.34 |
| ▸ | ERN1 | O75460 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 3/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3953309 | 0.86 | KMT2A (0.45) | KMT2AALDH1A1TDP1L3MBTL1POLB | |
| SCHEMBL896494 | 0.83 | CHRNA4 (0.47) | KMT2AALDH1A1ACLYHCAR2TDP1 | |
| SCHEMBL14397414 | 0.81 | KMT2A (0.34) | KMT2AALDH1A1ACLYTDP1KDM4E | |
| SCHEMBL21223078 | 0.81 | ALDH1A1 (0.35) | KMT2AALDH1A1TDP1ERN1KDM4E | |
| SCHEMBL3953306 | 0.78 | L3MBTL1 (0.45) | KMT2ATDP1L3MBTL1POLBESR1 | |
| SCHEMBL9510452 | 0.76 | KDM4E (0.38) | KMT2AALDH1A1TDP1KDM4EL3MBTL1 | |
| SCHEMBL30999728 | 0.76 | ALDH1A1 (0.43) | KMT2AALDH1A1ERN1KDM4EPOLB | |
| SCHEMBL18244972 | 0.75 | TRPA1 (0.44) | KMT2AALDH1A1HCAR2TDP1POLB | |
| SCHEMBL10405595 | 0.74 | ALDH1A1 (0.50) | KMT2AALDH1A1TDP1POLBAPEX1 | |
| SCHEMBL4947583 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117088833-B | Method for preparing formyl-2-furancarboxylic acid from 5-hydroxymethylfurfural | 烟台大学 | 2025-05-30 | — | — | CN | claimed |
| WO-2024176084-A1 | OXIDATION METHOD WITH REDUCED CARBON DIOXIDE EMISSON | STORA ENSO OYJ (FI) | 2024-08-29 | — | — | WO | claimed |
| US-12049456-B2 | Purified 2,5-furandicarboxylic acid pathway products | STORA ENSO OYJ (FI) | 2024-07-30 | — | — | US | claimed |
| EP-4332095-A1 | METHOD FOR PRODUCING FURAN DERIVATIVE INCLUDING 5-HYDROXYMETHYLFURFURAL (5-HMF), FURAN DERIVATIVE, SOLUTION CONTAINING SAID FURAN DERIVATIVE, AND METHOD FOR PRODUCING FURAN DICARBOXYLIC ACID OR FURAN DICARBOXYLIC ACID ESTER | Mitsubishi Chemical Corporation (JP) | 2024-03-06 | — | — | EP | claimed |
| CN-117088833-A | Method for preparing formyl-2-furancarboxylic acid from 5-hydroxymethylfurfural | 烟台大学 | 2023-11-21 | — | — | CN | claimed |
| WO-2022230769-A1 | METHOD FOR PRODUCING FURAN DERIVATIVE INCLUDING 5-HYDROXYMETHYLFURFURAL (5-HMF), FURAN DERIVATIVE, SOLUTION CONTAINING SAID FURAN DERIVATIVE, AND METHOD FOR PRODUCING FURAN DICARBOXYLIC ACID OR FURAN DICARBOXYLIC ACID ESTER | 三菱ケミカル株式会社 | 2022-11-03 | — | — | WO | claimed |
| US-20220153715-A1 | PURIFIED 2,5-FURANDICARBOXYLIC ACID PATHWAY PRODUCTS | STORA ENSO OYJ (FI) | 2022-05-19 | — | — | US | claimed |
| US-11192872-B2 | Purified 2,5-furandicarboxylic acid pathway products | STORA ENSO OYJ (FI) | 2021-12-07 | — | — | US | claimed |
| EP-3775249-A2 | PROCESS FOR OXIDISING A SUBSTRATE | Biome Bioplastics Limited (GB) | 2021-02-17 | — | — | EP | claimed |
| US-20210017556-A1 | PROCESS FOR OXIDISING A SUBSTRATE | BIOME BIOPLASTICS LIMITED (GB) | 2021-01-21 | — | — | US | claimed |
| CN-110997647-A | Purified 2, 5-furandicarboxylic acid pathway products | 斯道拉恩索公司 | 2020-04-10 | — | — | CN | claimed |
| WO-2019185646-A2 | PROCESS FOR OXIDISING A SUBSTRATE | BIOME BIOPLASTICS LIMITED (GB) | 2019-10-03 | — | — | WO | claimed |
| WO-2019156483-A1 | METHOD FOR PRODUCING FUNCTIONAL CRYSTALLINE SWEETENER | 주식회사 삼양사 | 2019-08-15 | — | — | WO | claimed |
| US-10344307-B2 | Processes for the formation of furandicarboxylic acid (FDCA) via a multistep biocatalytic oxidation reaction of 5-hydroxymethylfurfural (HMF) | BIOME BIOPLASTICS LIMITED (GB) | 2019-07-09 | — | — | US | claimed |
| WO-2019014382-A1 | PURIFIED 2,5-FURANDICARBOXYLIC ACID PATHWAY PRODUCTS | STORA ENSO OYJ (FI) | 2019-01-17 | — | — | WO | claimed |
| EP-3402787-A1 | PROCESSES FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF | Stora Enso Oyj (FI) | 2018-11-21 | — | — | EP | claimed |
| US-20180187224-A1 | PROCESSES FOR THE FORMATION OF FURANDICARBOXYLIC ACID (FDCA) VIA A MULTISTEP BIOCATALYTIC OXIDATION REACTION OF 5-HYDROXYMETHYLFURFURAL (HMF) | BIOME BIOPLASTICS LIMITED (GB) | 2018-07-05 | — | — | US | claimed |
| EP-3307764-A1 | PROCESSES FOR THE FORMATION OF FURANDICARBOXYLIC ACID (FDCA) VIA A MULTISTEP BIOCATALYTIC OXIDATION REACTION OF 5-HYDROXYMETHYLFURFURAL (HMF) | Biome Bioplastics Limited (GB) | 2018-04-18 | — | — | EP | claimed |
| WO-2017123763-A1 | PROCESSES FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF | RENNOVIA INC. (US) | 2017-07-20 | — | — | WO | claimed |
| WO-2016202858-A1 | PROCESSES FOR THE FORMATION OF FURANDICARBOXYLIC ACID (FDCA) VIA A MULTISTEP BIOCATALYTIC OXIDATION REACTION OF 5-HYDROXYMETHYLFURFURAL (HMF) | BIOME BIOPLASTICS LIMITED (GB) | 2016-12-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12049456-B2 | Purified 2,5-furandicarboxylic acid pathway products | FDPS, HPD, FLAD1 | KMT2A 3987/4885ALDH1A1 586/4885ACLY 457/4885 |
| US-20220153715-A1 | PURIFIED 2,5-FURANDICARBOXYLIC ACID PATHWAY PRODUCTS | FDPS, HPD, FLAD1 | KMT2A 3987/4885ALDH1A1 586/4885ACLY 457/4885 |
| US-11192872-B2 | Purified 2,5-furandicarboxylic acid pathway products | FDPS, HPD, FLAD1 | KMT2A 3987/4885ALDH1A1 586/4885ACLY 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.